HU176180B - Process for preparing antigenic compositions - Google Patents

Process for preparing antigenic compositions Download PDF

Info

Publication number
HU176180B
HU176180B HU76WE542A HUWE000542A HU176180B HU 176180 B HU176180 B HU 176180B HU 76WE542 A HU76WE542 A HU 76WE542A HU WE000542 A HUWE000542 A HU WE000542A HU 176180 B HU176180 B HU 176180B
Authority
HU
Hungary
Prior art keywords
antigenic protein
lipoid
mixing
solution
added
Prior art date
Application number
HU76WE542A
Other languages
English (en)
Hungarian (hu)
Inventor
June D Almeida
David C Edwards
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HU176180B publication Critical patent/HU176180B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU76WE542A 1975-09-29 1976-09-28 Process for preparing antigenic compositions HU176180B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39857/75A GB1564500A (en) 1975-09-29 1975-09-29 Biological preparations

Publications (1)

Publication Number Publication Date
HU176180B true HU176180B (en) 1980-12-28

Family

ID=10411873

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76WE542A HU176180B (en) 1975-09-29 1976-09-28 Process for preparing antigenic compositions

Country Status (15)

Country Link
JP (1) JPS5244228A (pl)
AU (1) AU514848B2 (pl)
BE (1) BE846681A (pl)
BG (1) BG34181A3 (pl)
CA (1) CA1079634A (pl)
DD (1) DD127598A5 (pl)
DE (1) DE2643641A1 (pl)
ES (1) ES451923A1 (pl)
FR (1) FR2325387A1 (pl)
GB (1) GB1564500A (pl)
HU (1) HU176180B (pl)
NL (1) NL7610736A (pl)
PL (1) PL103082B1 (pl)
SE (1) SE7610708L (pl)
ZA (1) ZA765817B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
US4196191A (en) 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4201767A (en) * 1978-11-08 1980-05-06 Merck & Co., Inc. Viral liposome particle
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
FR2543018B1 (fr) * 1983-03-22 1985-07-26 Oreal Procede de preparation de vesicules lipidiques par vaporisation de solvants
IT1238343B (it) * 1989-10-16 1993-07-13 Cesalpino Andrea Fond Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche
CA2131442A1 (en) * 1992-03-03 1993-09-04 Seishi Tsuchiya Oral vaccine
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
CN105899220B (zh) * 2013-12-19 2020-01-10 扬森疫苗与预防公司 改进的病毒体配制品

Also Published As

Publication number Publication date
NL7610736A (nl) 1977-03-31
SE7610708L (sv) 1977-03-30
ES451923A1 (es) 1977-08-16
AU514848B2 (en) 1981-03-05
FR2325387A1 (fr) 1977-04-22
PL103082B1 (pl) 1979-05-31
BG34181A3 (en) 1983-07-15
BE846681A (fr) 1977-03-28
DD127598A5 (de) 1977-10-05
DE2643641A1 (de) 1977-04-14
ZA765817B (en) 1978-05-30
CA1079634A (en) 1980-06-17
GB1564500A (en) 1980-04-10
FR2325387B1 (pl) 1980-06-27
JPS5244228A (en) 1977-04-07
AU1816476A (en) 1978-04-06

Similar Documents

Publication Publication Date Title
US4196191A (en) Biological preparations
US4148876A (en) Biological preparations
JP3923518B2 (ja) ワクチン組成物用アジュバント
EP0356339B1 (en) Influenza vaccine and novel adjuvants
US6090406A (en) Potentiation of immune responses with liposomal adjuvants
US5916588A (en) Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
JP4010462B2 (ja) インフルエンザワクチン組成物
US6261573B1 (en) Immunoadjuvants
CN107296792B (zh) 囊泡及由其产生之制剂的制备方法
HU176180B (en) Process for preparing antigenic compositions
JP2000513352A (ja) リポソームインフルエンザワクチンの組成物および方法
AU689505B2 (en) Protein- or peptide-cochleate vaccines and methods of immunizing using the same
EP2058002A1 (en) Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine
JP2010105968A (ja) カチオン性ナノゲルを用いる粘膜ワクチン
JP2001523216A (ja) 新規のアジュバント組成物と、それからなるワクチン製剤
US9540420B2 (en) Mucosal vaccines
US6890540B1 (en) Vaccine formulation
US8287887B2 (en) Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
Gregoriadis et al. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen
Boudreault et al. Mouse response to influenza immunosomes
DE69127975T2 (de) Impfstoffe
US5985318A (en) Fusogenic liposomes that are free of active neuraminidase
PT1346727E (pt) Método para a obtenção de agregados antigénicos e a sua utilização em formulações
KR20220135935A (ko) 제형화된 모노포스포릴 지질 a를 포함하는 면역증강용 조성물 및 그의 제조방법
KR0137360B1 (ko) 인플루엔자 백신과 새로운 보조제